|
Multi-Payer Claims Database
|
Resource Development
|
AHRQ, OS
|
NIA, OD/OSP
|
The goals of the Multi-Payer Claims Database (MPCD) Pilot is to evaluate the value of a multi-payer claims database for comparative effectiveness research. The database will combine public and private claims data, providing investigators with access to data on a broad patient population.
|
|
Multinational Influenza Seasonal Mortality Study (MISMS) Research
|
Research Initiative
|
OS
|
FIC, NHLBI, NIAID, NLM
|
The Multinational Influenza Seasonal Mortality Study (MISMS) was originally initiated to analyze national and global mortality patterns associated with influenza virus circulation. The focus of MISMS has since expanded to evaluate the interaction between the epidemiology, ecology, and evolutionary dynamics of influenza, including natural selection, reassortment, migration, and antigenic change. Multinational and bilateral collaborations developed by MISMS collect, analyze, and disseminate research findings through scientific publications, training workshops, and communication tools for investigators and decision-makers. Our research findings inform numerous national governments, multilateral organizations, and research stakeholders on interventions for both pandemic and seasonal influenza. To date, data have been acquired from more than 30 countries (representing ~3.2 billion people), resulting in over 100 publications.
|
|
Muscular Dystrophy Coordinating Committee (MDCC)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, FDA, HRSA
|
NINDS, NHLBI, NIAMS, NICHD
|
This Committee coordinates activities across NIH and with other Federal health programs and activities relevant to the various forms of muscular dystrophy.
|
|
My Pregnancy Management Team
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, HRSA
|
NICHD, NCCAM, NHLBI, NINR, OD/DPCPSI/ORWH
|
The purpose of this committee is to collaborate with other NIH ICs and other HHS agencies for the purpose of research involving more positive pregnancy outcomes.
|
|
Naloxone Workgroup
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NIDA
|
The goal of this Workgroup is to discuss ways to implement the use of naloxone as emergency treatment for opioid overdose.
|
|
Nanomaterial Registry
|
Resource Development
|
FDA
|
NCI, NIBIB, NIEHS
|
The Nanomaterial Registry is an authoritative, fully curated resource available to the public that archives research data on nanomaterials and their biological and environmental implications.
|
|
Nanotechnology Characterization Laboratory
|
Research Initiative
|
FDA
|
NCI, NIEHS
|
The Nanotechnology Characterization Laboratory (NCL) performs and standardizes the preclinical characterization of nanomaterials intended for cancer therapeutics and diagnostics developed by researchers from academia, government, and industry. The NCL serves as a national resource and knowledge base for cancer researchers and facilitates the development and translation of nanoscale particles and devices for clinical applications.
|
|
National Action Alliance for Suicide Prevention (NAASP)
|
Committee, Work group, Advisory group, or Task Force
|
ACL, CDC, HRSA, IHS, OS, OSG, SAMHSA
|
NIMH, NIAAA, NIDA, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP
|
The National Action Alliance for Suicide Prevention (NAASP) is a public-private partnership for advancing the National Strategy for Suicide Prevention. The mission of the NAASP is to champion suicide prevention as a national priority; to catalyze efforts to implement high priority objectives of the NAASP; and to cultivate the resources needed to sustain progress. The NIMH Director is an ex officio member of the NAASP Executive Committee and Co-Chair of the NAASP Research Task Force. Additional NIMH staff serve on task forces pertaining to LGBT Youth, Military and Veterans, Youth in Justice Settings, and American Indian/Alaska Natives. In 2014, NIMH staff contributed to and served as guest editors, authors, and co-authors of the supplement. Also, the National Action Alliance for Suicide Prevention’s Research Prioritization Task Force released the Nation’s first suicide research agenda: A Prioritized Research Agenda for Suicide Prevention: An Action Plan to Save Lives. The Research Agenda includes an overarching goal to advance suicide prevention research more rapidly, seeking ways to reduce suicide deaths and attempts by 20% in five years and by 40% or greater in 10 years, if multiple actions, informed by research, were fully implemented.
|
|
National Advisory Board for Medical Rehabilitation Research
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS
|
NICHD, CSR, NCATS, NCI, NHLBI, NIA, NIAMS, NIBIB, NIDCR, NINDS, NINR
|
The Board meets twice a year to advise the directors of the NIH, the Eunice Kennedy Shriver National Institutute of Child Health and Human Development (NICHD), and the National Center for Medical Rehabilitation Research (NCMRR) on matters and policies relating to the Center''s programs. The Board comprises 12 members representing health and scientific disciplines related to medical rehabilitation and 6 members representing persons with disabilities.
|
|
National Ambulatory Medical Care Survey (NAMCS) Asthma Supplement - Interagency agreement with CDC/NCHS
|
Health Survey
|
AHRQ, CDC
|
NIEHS, NHLBI, NIAID, NICHD
|
Developed a survey of a national sample of primary care health providers and specialists likely to see asthma patients to gauge implementation of the NHLBI Guidelines for the Diagnosis and Management of Asthma.
|